These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9443032)

  • 1. The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
    Bidziñski M; Lemieszczuk B; Drabik M
    Eur J Gynaecol Oncol; 1997; 18(6):541-3. PubMed ID: 9443032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
    Kohorn EI
    J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
    Matsui H; Iitsuka Y; Seki K; Sekiya S
    Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
    Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
    Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etoposide (VP-16) in gynecologic malignancy].
    Kanazawa K; Moromizato H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1925-8. PubMed ID: 8978799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvaginal ultrasonography in persistent trophoblastic tumor.
    Mangili G; Spagnolo D; Valsecchi L; Maggi R
    Am J Obstet Gynecol; 1993 Nov; 169(5):1218-23. PubMed ID: 8238187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
    Gallion HH; van Nagell JR; Donaldson ES; Higgins RV
    Gynecol Oncol; 1989 Jul; 34(1):98-100. PubMed ID: 2544491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
    Surwit EA; Childers JM
    J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent gestational trophoblastic disease following in-vitro fertilization.
    Tanos V; Meirow D; Reubinoff BE; Anteby SO
    Hum Reprod; 1994 Nov; 9(11):2010-3. PubMed ID: 7532652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal color Doppler studies in gestational trophoblastic disease.
    Kawano M; Masuzaki H; Ishimaru T
    Ultrasound Obstet Gynecol; 1996 Mar; 7(3):197-200. PubMed ID: 8705413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of color Doppler flow in the management of nonmetastatic gestational trophoblastic disease.
    Tepper R; Shulman A; Altaras M; Goldberger S; Maymon R; Holzinger M; Beyth Y
    Gynecol Obstet Invest; 1994; 38(1):14-7. PubMed ID: 7959318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for trophoblastic neoplasms in the Philippines.
    Gonzales RB
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):669-74. PubMed ID: 3012792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of gestational trophoblastic disease at a single institute.
    Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
    Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with gestational trophoblastic neoplasia: experience of the Southeastern Regional Center.
    Hammond CB; Clarke-Pearson DL; Soper JT
    Adv Exp Med Biol; 1984; 176():369-81. PubMed ID: 6093469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.